vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Riley Exploration Permian, Inc.（REPX）财务数据对比。点击上方公司名可切换其他公司
Riley Exploration Permian, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.3倍（$97.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -5.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -1.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Riley Exploration Permian, Inc.是一家独立能源企业，专注于美国得克萨斯州与新墨西哥州境内的二叠纪盆地，开展原油、天然气及天然气凝析液的勘探、开发与生产业务，主打低成本陆上储备开发，为北美市场供应稳定能源产品。
PBYI vs REPX — 直观对比
营收规模更大
REPX
是对方的1.3倍
$75.5M
营收增速更快
PBYI
高出33.0%
-5.3%
两年增速更快
PBYI
近两年复合增速
-1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $97.3M |
| 净利润 | — | — |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 26.9% |
| 净利率 | — | — |
| 营收同比 | 27.7% | -5.3% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.26 | $4.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIREPX
| Q4 25 | $75.5M | $97.3M | ||
| Q3 25 | $54.5M | $106.9M | ||
| Q2 25 | $52.4M | $85.4M | ||
| Q1 25 | $46.0M | $102.5M | ||
| Q4 24 | $59.1M | $102.7M | ||
| Q3 24 | $80.5M | $102.3M | ||
| Q2 24 | $47.1M | $105.4M | ||
| Q1 24 | $43.8M | $99.7M |
净利润PBYIREPX
| Q4 25 | — | — | ||
| Q3 25 | $8.8M | $16.3M | ||
| Q2 25 | $5.9M | $30.5M | ||
| Q1 25 | $3.0M | $28.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | $20.3M | $25.7M | ||
| Q2 24 | $-4.5M | $33.5M | ||
| Q1 24 | $-4.8M | $18.8M |
毛利率PBYIREPX
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIREPX
| Q4 25 | 22.7% | 26.9% | ||
| Q3 25 | 17.6% | 27.0% | ||
| Q2 25 | 12.7% | 33.7% | ||
| Q1 25 | 8.7% | 48.3% | ||
| Q4 24 | 22.6% | 31.2% | ||
| Q3 24 | 27.4% | 17.1% | ||
| Q2 24 | -4.6% | 50.9% | ||
| Q1 24 | -5.3% | 50.7% |
净利率PBYIREPX
| Q4 25 | — | — | ||
| Q3 25 | 16.2% | 15.3% | ||
| Q2 25 | 11.2% | 35.7% | ||
| Q1 25 | 6.5% | 27.9% | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | 25.1% | ||
| Q2 24 | -9.6% | 31.8% | ||
| Q1 24 | -11.0% | 18.8% |
每股收益（稀释后）PBYIREPX
| Q4 25 | $0.26 | $4.02 | ||
| Q3 25 | $0.17 | $0.77 | ||
| Q2 25 | $0.12 | $1.44 | ||
| Q1 25 | $0.06 | $1.36 | ||
| Q4 24 | $0.40 | $0.52 | ||
| Q3 24 | $0.41 | $1.21 | ||
| Q2 24 | $-0.09 | $1.59 | ||
| Q1 24 | $-0.10 | $0.94 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | — |
| 总债务越低越好 | $22.7M | $247.9M |
| 股东权益账面价值 | $130.3M | $634.2M |
| 总资产 | $216.3M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.17× | 0.39× |
8季度趋势，按日历期对齐
现金及短期投资PBYIREPX
| Q4 25 | $97.5M | — | ||
| Q3 25 | $94.4M | — | ||
| Q2 25 | $96.0M | — | ||
| Q1 25 | $93.2M | — | ||
| Q4 24 | $101.0M | — | ||
| Q3 24 | $96.7M | — | ||
| Q2 24 | $96.8M | — | ||
| Q1 24 | $107.2M | — |
总债务PBYIREPX
| Q4 25 | $22.7M | $247.9M | ||
| Q3 25 | $34.0M | $367.0M | ||
| Q2 25 | $45.3M | $275.2M | ||
| Q1 25 | $56.7M | $249.3M | ||
| Q4 24 | $68.0M | $269.5M | ||
| Q3 24 | $79.3M | $288.6M | ||
| Q2 24 | $90.7M | $322.7M | ||
| Q1 24 | $102.0M | $341.8M |
股东权益PBYIREPX
| Q4 25 | $130.3M | $634.2M | ||
| Q3 25 | $115.3M | $566.5M | ||
| Q2 25 | $104.7M | $556.9M | ||
| Q1 25 | $97.1M | $532.4M | ||
| Q4 24 | $92.1M | $510.6M | ||
| Q3 24 | $71.1M | $507.4M | ||
| Q2 24 | $48.5M | $489.0M | ||
| Q1 24 | $51.0M | $434.6M |
总资产PBYIREPX
| Q4 25 | $216.3M | $1.2B | ||
| Q3 25 | $202.9M | $1.2B | ||
| Q2 25 | $194.9M | $1.0B | ||
| Q1 25 | $196.2M | $994.9M | ||
| Q4 24 | $213.3M | $993.5M | ||
| Q3 24 | $220.7M | $997.9M | ||
| Q2 24 | $205.0M | $1.0B | ||
| Q1 24 | $214.1M | $956.4M |
负债/权益比PBYIREPX
| Q4 25 | 0.17× | 0.39× | ||
| Q3 25 | 0.30× | 0.65× | ||
| Q2 25 | 0.43× | 0.49× | ||
| Q1 25 | 0.58× | 0.47× | ||
| Q4 24 | 0.74× | 0.53× | ||
| Q3 24 | 1.12× | 0.57× | ||
| Q2 24 | 1.87× | 0.66× | ||
| Q1 24 | 2.00× | 0.79× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $64.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIREPX
| Q4 25 | $14.4M | $64.9M | ||
| Q3 25 | $9.7M | $63.6M | ||
| Q2 25 | $14.1M | $33.6M | ||
| Q1 25 | $3.6M | $50.4M | ||
| Q4 24 | $15.6M | $66.4M | ||
| Q3 24 | $11.0M | $72.1M | ||
| Q2 24 | $1.0M | $51.6M | ||
| Q1 24 | $11.2M | $56.1M |
自由现金流PBYIREPX
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIREPX
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIREPX
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIREPX
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | 3.90× | ||
| Q2 25 | 2.41× | 1.10× | ||
| Q1 25 | 1.21× | 1.76× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | 2.81× | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | — | 2.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
